Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
33%
OVERLAP
BY WEIGHT
22
# OF OVERLAPPING
HOLDINGS
PBE
27
HOLDINGS
81%
ALSO IN IBB
IBB
252
HOLDINGS
10%
ALSO IN PBE
SECTOR DRIFT (PBE minus IBB)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PBE |
Weight in IBB |
Overlap | |
---|---|---|---|---|
ALNYLAM PHARMACEUTICALS INC | 7.5% | 6.2% | 6.2% | |
GILEAD SCIENCES INC | 5.4% | 8.1% | 5.4% | |
AMGEN INC | 5.1% | 7.5% | 5.1% | |
VERTEX PHARMACEUTICALS INC | 4.1% | 6.2% | 4.1% | |
INCYTE CORP | 3.3% | 1.7% | 1.7% |
PBE Overweight Relative to IBB
ROYALTY PHARMA PLC CLASS A | 5.7% | |
ILLUMINA INC | 4.0% | |
ANAVEX LIFE SCIENCES CORP. | 4.0% | |
BIOMARIN PHARMACEUTICAL INC | 3.7% | |
UNITED THERAPEUTICS CORP | 3.2% | |
COLLEGIUM PHARMACEUTICAL, INC. | 3.2% | |
DYNAVAX TECHNOLOGIES CORP | 2.7% | |
AMICUS THERAPEUTICS INC | 2.7% | |
ARROWHEAD PHARMACEUTICALS, INC. | 2.7% | |
PROTAGONIST THERAPEUTICS, INC. | 2.6% |
PBE Underweight Relative to IBB
REGENERON PHARMACEUTICALS | -6.7% | |
IQVIA HOLDINGS INC | -3.5% | |
METTLER-TOLEDO INTERNATIONAL | -3.0% | |
ARGENX SE ADR | -2.9% | |
GILEAD SCIENCES INC | -2.7% | |
AMGEN INC | -2.3% | |
NATERA INC | -2.2% | |
INSMED INC | -2.2% | |
BIOGEN IDEC INC | -2.2% | |
VERTEX PHARMACEUTICALS INC | -2.1% |